Skip to main content
Top
Published in: Molecular Cancer 1/2011

Open Access 01-12-2011 | Research

Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential

Authors: Ingeborg Zehbe, Hava Lichtig, Ashley Westerback, Paul F Lambert, Massimo Tommasino, Levana Sherman

Published in: Molecular Cancer | Issue 1/2011

Login to get access

Abstract

The aim of this study was to determine whether low prevalence human papillomavirus (HPV) 16 E6 variants differ from high prevalence types in their functional abilities. We evaluated functions relevant to carcinogenesis for the rarely-detected European variants R8Q, R10G and R48W as compared to the commonly detected L83V. Human immortalized keratinocytes (NIKS) stably transduced with the E6 variants were used in most functional assays. Low and high prevalence E6 variants displayed similar abilities in abrogation of growth arrest and inhibition of p53 elevation induced by actinomycin D. Differences were detected in the abilities to dysregulate stratification and differentiation of NIKS in organotypic raft cultures, modulate detachment induced apoptosis (anoikis) and hyperactivate Wnt signaling. No distinctive phenotype could be assigned to include all rare variants. Like L83V, raft cultures derived from variants R10G and R48W similarly induced hyperplasia and aberrantly expressed keratin 5 in the suprabasal compartment with significantly lower expression of keratin 10. Unlike L83V, both variants, and particularly R48W, induced increased levels of anoikis upon suspension in semisolid medium. R8Q induced a unique phenotype characterized by thin organotypic raft cultures, low expression of keratin 10, and high expression of keratins 5 and 14 throughout all raft layers. Interestingly, in a reporter based assay R8Q exhibited a higher ability to augment TCF/β-catenin transcription. The data suggests that differences in E6 variant prevalence in cervical carcinoma may not be related to the carcinogenic potential of the E6 protein.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zur Hausen H: Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta. 1996, 1288: 55-78. Zur Hausen H: Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta. 1996, 1288: 55-78.
2.
3.
go back to reference Castellsague X: Natural history and epidemiology of HPV infection and cervical cancer. Gynecologic Oncology. 2008, 110: S4-S7. 10.1016/j.ygyno.2008.07.045CrossRefPubMed Castellsague X: Natural history and epidemiology of HPV infection and cervical cancer. Gynecologic Oncology. 2008, 110: S4-S7. 10.1016/j.ygyno.2008.07.045CrossRefPubMed
4.
go back to reference Lizano M, Berumen J, Garcia-Carranca A: HPV-related carcinogenesis: Basic concepts, viral types and variants. Arch Med Res. 2009, 40: 428-434. 10.1016/j.arcmed.2009.06.001CrossRefPubMed Lizano M, Berumen J, Garcia-Carranca A: HPV-related carcinogenesis: Basic concepts, viral types and variants. Arch Med Res. 2009, 40: 428-434. 10.1016/j.arcmed.2009.06.001CrossRefPubMed
5.
go back to reference Bernard HU, Calleja-Macias IE, Dunn ST: Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer. 2006, 118 (5): 1071-1076. 10.1002/ijc.21655CrossRefPubMed Bernard HU, Calleja-Macias IE, Dunn ST: Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer. 2006, 118 (5): 1071-1076. 10.1002/ijc.21655CrossRefPubMed
6.
go back to reference Tidy JA, Vousden KH, Farrell PJ: Relation between infection with a subtype of HPV16 and cervical neoplasia. Lancet. 1989, 1 (8649): 1225-1227. 10.1016/S0140-6736(89)92329-5CrossRefPubMed Tidy JA, Vousden KH, Farrell PJ: Relation between infection with a subtype of HPV16 and cervical neoplasia. Lancet. 1989, 1 (8649): 1225-1227. 10.1016/S0140-6736(89)92329-5CrossRefPubMed
7.
go back to reference Zehbe I, Wilander E, Delius H, Tommasino M: Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998, 58: 829-833.PubMed Zehbe I, Wilander E, Delius H, Tommasino M: Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998, 58: 829-833.PubMed
8.
go back to reference Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M: Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet. 1998, 352: 1441-1442. 10.1016/S0140-6736(05)61263-9CrossRefPubMed Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M: Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet. 1998, 352: 1441-1442. 10.1016/S0140-6736(05)61263-9CrossRefPubMed
9.
go back to reference Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK, Galloway DA: Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis. 1995, 172: 747-755. 10.1093/infdis/172.3.747CrossRefPubMed Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK, Galloway DA: Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis. 1995, 172: 747-755. 10.1093/infdis/172.3.747CrossRefPubMed
10.
go back to reference Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL: Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007, 16: 4-10.CrossRefPubMed Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL: Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007, 16: 4-10.CrossRefPubMed
11.
go back to reference Zehbe I, Voglino G, Wilander E, Delius H, Edler L, Klimek F, Andersson S, Tommasino M: p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res. 2001, 61: 608-611.PubMed Zehbe I, Voglino G, Wilander E, Delius H, Edler L, Klimek F, Andersson S, Tommasino M: p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res. 2001, 61: 608-611.PubMed
12.
go back to reference Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Gissmann L, Wilander E, Tommasino M: Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer. 2001, 94: 711-716. 10.1002/ijc.1520CrossRefPubMed Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Gissmann L, Wilander E, Tommasino M: Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer. 2001, 94: 711-716. 10.1002/ijc.1520CrossRefPubMed
13.
go back to reference Berumen J, Ordonez RM, Lazcanao E, Salmeron E, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de-la-Campa A: Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst. 2001, 93: 1325-1330. 10.1093/jnci/93.17.1325CrossRefPubMed Berumen J, Ordonez RM, Lazcanao E, Salmeron E, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de-la-Campa A: Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst. 2001, 93: 1325-1330. 10.1093/jnci/93.17.1325CrossRefPubMed
14.
go back to reference Kämmer C, Tommasino M, Syrjanen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I: Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer. 2002, 86: 269-273. 10.1038/sj.bjc.6600024PubMedCentralCrossRefPubMed Kämmer C, Tommasino M, Syrjanen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I: Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer. 2002, 86: 269-273. 10.1038/sj.bjc.6600024PubMedCentralCrossRefPubMed
15.
go back to reference Xi LF, Koutski LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RI: Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007, 16: 4-10.CrossRefPubMed Xi LF, Koutski LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RI: Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007, 16: 4-10.CrossRefPubMed
16.
go back to reference Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A: Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer. 1996, 69: 364-368. 10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3CrossRefPubMed Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A: Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer. 1996, 69: 364-368. 10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3CrossRefPubMed
17.
go back to reference Ferenczy A, Franco E: Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol. 2002, 3: 11-16. 10.1016/S1470-2045(01)00617-9CrossRefPubMed Ferenczy A, Franco E: Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol. 2002, 3: 11-16. 10.1016/S1470-2045(01)00617-9CrossRefPubMed
18.
go back to reference Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, Koutski LA: Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst. 2006, 98: 1045-1052. 10.1093/jnci/djj297CrossRefPubMed Xi LF, Kiviat NB, Hildesheim A, Galloway DA, Wheeler CM, Ho J, Koutski LA: Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst. 2006, 98: 1045-1052. 10.1093/jnci/djj297CrossRefPubMed
19.
go back to reference Grodzki M, Besson G, Clavel C, Franceschi S, Arslan A, Birembaut P, Tommasino M, Zehbe I: Increased risk for cervical disease progression of French women infected with the human papillomavirus 16 E6-350G variant. Cancer Epidemiol Biomarker Prev. 2006, 15: 820-822. 10.1158/1055-9965.EPI-05-0864.CrossRef Grodzki M, Besson G, Clavel C, Franceschi S, Arslan A, Birembaut P, Tommasino M, Zehbe I: Increased risk for cervical disease progression of French women infected with the human papillomavirus 16 E6-350G variant. Cancer Epidemiol Biomarker Prev. 2006, 15: 820-822. 10.1158/1055-9965.EPI-05-0864.CrossRef
20.
go back to reference Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL: High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer. 2007, 120: 1763-1768. 10.1002/ijc.22481CrossRefPubMed Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL: High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer. 2007, 120: 1763-1768. 10.1002/ijc.22481CrossRefPubMed
21.
go back to reference Lee K, Magalhaes I, Clavel C, Birembaut P, Tommasino M, Zehbe I: Distribution of human papillomavirus 16 E6, L1, L2 and E2 gene variants in pre-malignant cervical disease. Virus Res. 2008, 131: 106-110.CrossRefPubMed Lee K, Magalhaes I, Clavel C, Birembaut P, Tommasino M, Zehbe I: Distribution of human papillomavirus 16 E6, L1, L2 and E2 gene variants in pre-malignant cervical disease. Virus Res. 2008, 131: 106-110.CrossRefPubMed
22.
go back to reference Conrad-Stoppler M, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J: Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol. 1996, 70 (10): 6987-6993. Conrad-Stoppler M, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J: Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol. 1996, 70 (10): 6987-6993.
23.
go back to reference Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, Stanley MA, Krishna S: Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol. 2004, 78: 5934-5945. 10.1128/JVI.78.11.5934-5945.2004PubMedCentralCrossRefPubMed Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, Stanley MA, Krishna S: Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol. 2004, 78: 5934-5945. 10.1128/JVI.78.11.5934-5945.2004PubMedCentralCrossRefPubMed
24.
go back to reference Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, Tommasino M, Zehbe I, Sherman L: HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology. 2006, 350: 216-227. 10.1016/j.virol.2006.01.038CrossRefPubMed Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, Tommasino M, Zehbe I, Sherman L: HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology. 2006, 350: 216-227. 10.1016/j.virol.2006.01.038CrossRefPubMed
25.
go back to reference Asadurian Y, Kurilin H, Lichtig H, Jackman A, Gonen P, Tommasino M, Zehbe I, Sherman L: Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J Med Virol. 2007, 79: 1751-1760. 10.1002/jmv.20978CrossRefPubMed Asadurian Y, Kurilin H, Lichtig H, Jackman A, Gonen P, Tommasino M, Zehbe I, Sherman L: Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J Med Virol. 2007, 79: 1751-1760. 10.1002/jmv.20978CrossRefPubMed
26.
go back to reference Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, Lichtig H, Tommasino M, Sherman L: Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology. 2009, 383: 69-77. 10.1016/j.virol.2008.09.036PubMedCentralCrossRefPubMed Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, Lichtig H, Tommasino M, Sherman L: Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology. 2009, 383: 69-77. 10.1016/j.virol.2008.09.036PubMedCentralCrossRefPubMed
27.
go back to reference Richard C, Lanner C, Naryzhny SN, Sherman L, Lee H, Lambert PF, Zehbe I: The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalence in cervical cancer. Oncogene. 2010, 29: 3435-3445. 10.1038/onc.2010.93CrossRefPubMed Richard C, Lanner C, Naryzhny SN, Sherman L, Lee H, Lambert PF, Zehbe I: The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalence in cervical cancer. Oncogene. 2010, 29: 3435-3445. 10.1038/onc.2010.93CrossRefPubMed
28.
go back to reference Golan M, Hizi A, Resau JH, Yaal-Hohoshen N, Reichman H, Keydar I, Tsarfaty I: Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia. 2008, 10: 521-533.PubMedCentralCrossRefPubMed Golan M, Hizi A, Resau JH, Yaal-Hohoshen N, Reichman H, Keydar I, Tsarfaty I: Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia. 2008, 10: 521-533.PubMedCentralCrossRefPubMed
29.
go back to reference Lichtig H, Gilboa A, Jackman A, Gonen P, Levav-Cohen Y, Haupt Y, Sherman L: HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. Virology. 2010, 396: 47-58. 10.1016/j.virol.2009.10.011CrossRefPubMed Lichtig H, Gilboa A, Jackman A, Gonen P, Levav-Cohen Y, Haupt Y, Sherman L: HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. Virology. 2010, 396: 47-58. 10.1016/j.virol.2009.10.011CrossRefPubMed
30.
go back to reference Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Hedrick L, Cho KR: Human papillomavirus 16 E6 expression disrupts the 53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA. 1993, 90: 3988-3992. 10.1073/pnas.90.9.3988PubMedCentralCrossRefPubMed Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Hedrick L, Cho KR: Human papillomavirus 16 E6 expression disrupts the 53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA. 1993, 90: 3988-3992. 10.1073/pnas.90.9.3988PubMedCentralCrossRefPubMed
31.
go back to reference Foster SA, Demers GW, Etscheid BG, Galloway DA: The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virology. 1994, 68: 5698-5705.PubMedCentralPubMed Foster SA, Demers GW, Etscheid BG, Galloway DA: The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virology. 1994, 68: 5698-5705.PubMedCentralPubMed
32.
go back to reference Mack JA, Anand S, Maytin EV: Proliferation and cornification during development of the mammalian epidermis. Birth Defects Research (Part C). 2005, 75: 314-329. 10.1002/bdrc.20055.CrossRef Mack JA, Anand S, Maytin EV: Proliferation and cornification during development of the mammalian epidermis. Birth Defects Research (Part C). 2005, 75: 314-329. 10.1002/bdrc.20055.CrossRef
33.
go back to reference Koster MI, Roop DR: Mechanisms regulating epithelial stratification. Ann Rev Cell Dev Biol. 2007, 23: 93-113. 10.1146/annurev.cellbio.23.090506.123357.CrossRef Koster MI, Roop DR: Mechanisms regulating epithelial stratification. Ann Rev Cell Dev Biol. 2007, 23: 93-113. 10.1146/annurev.cellbio.23.090506.123357.CrossRef
34.
go back to reference Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL: Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol. 2000, 114: 444-455. 10.1046/j.1523-1747.2000.00869.xCrossRefPubMed Allen-Hoffmann BL, Schlosser SJ, Ivarie CA, Sattler CA, Meisner LF, O'Connor SL: Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J Invest Dermatol. 2000, 114: 444-455. 10.1046/j.1523-1747.2000.00869.xCrossRefPubMed
35.
go back to reference Hansen LA, Woodson RL, Holbu S, Strain K, Lo YC, Yuspa SH: The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. Cancer Res. 2000, 60: 3328-3332.PubMed Hansen LA, Woodson RL, Holbu S, Strain K, Lo YC, Yuspa SH: The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. Cancer Res. 2000, 60: 3328-3332.PubMed
36.
go back to reference Huitfeldt HS, Heyden A, Clausen OP, Thrane EV, Roop D, Yuspa SH: Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumors. Carcinogenesis. 1991, 12: 2063-2067. 10.1093/carcin/12.11.2063CrossRefPubMed Huitfeldt HS, Heyden A, Clausen OP, Thrane EV, Roop D, Yuspa SH: Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumors. Carcinogenesis. 1991, 12: 2063-2067. 10.1093/carcin/12.11.2063CrossRefPubMed
37.
go back to reference Marconi A, Atzei P, Panza C, Fila C, Tiberio R, Truzzi F, Wachter T, Leverkus M, Pincelli C: FLICE/caspase-8 activation triggers anoikis induced by beta1-integrin blockade in human keratinocytes. J Cell Sci. 2004, 117: 815-823. 10.1242/jcs.01080CrossRef Marconi A, Atzei P, Panza C, Fila C, Tiberio R, Truzzi F, Wachter T, Leverkus M, Pincelli C: FLICE/caspase-8 activation triggers anoikis induced by beta1-integrin blockade in human keratinocytes. J Cell Sci. 2004, 117: 815-823. 10.1242/jcs.01080CrossRef
38.
go back to reference Uren A, Fallen S, Yuan H, Usubutun A, Kucukali T, Schlegel R, Toretsky JA: Activation of the canonical Wnt pathway during genital keratinocyte transformation: A model for cervical cancer progression. Cancer Res. 2005, 65: 6199-6206. 10.1158/0008-5472.CAN-05-0455CrossRefPubMed Uren A, Fallen S, Yuan H, Usubutun A, Kucukali T, Schlegel R, Toretsky JA: Activation of the canonical Wnt pathway during genital keratinocyte transformation: A model for cervical cancer progression. Cancer Res. 2005, 65: 6199-6206. 10.1158/0008-5472.CAN-05-0455CrossRefPubMed
39.
go back to reference Perez-Pereira C, Vazquez-Ortiz G, Lopez-Romero R, Pina-Sanchez P, Moreno J, Salcedo M: Genome wide expression analysis in HPV cervical cancer: identification of altered metabolic pathways. Infect Agent Cancer. 2007, 2: 16-26. 10.1186/1750-9378-2-16CrossRef Perez-Pereira C, Vazquez-Ortiz G, Lopez-Romero R, Pina-Sanchez P, Moreno J, Salcedo M: Genome wide expression analysis in HPV cervical cancer: identification of altered metabolic pathways. Infect Agent Cancer. 2007, 2: 16-26. 10.1186/1750-9378-2-16CrossRef
41.
go back to reference Blanton RA, Perez-Reyes N, Merrick DT, McDougall JK: Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am J Pathol. 1991, 138: 673-85.PubMedCentralPubMed Blanton RA, Perez-Reyes N, Merrick DT, McDougall JK: Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am J Pathol. 1991, 138: 673-85.PubMedCentralPubMed
42.
go back to reference McCance DJ, Kopan R, Fuchs E, Laimins LA: Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA. 1989, 85: 7169-7173.CrossRef McCance DJ, Kopan R, Fuchs E, Laimins LA: Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA. 1989, 85: 7169-7173.CrossRef
43.
go back to reference Ruiz S, Santos M, Segrelles C, Leis H, Jorcano JL, Berns A, Paramio JM, Vooijs M: Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development. 2004, 131: 2737-2748. 10.1242/dev.01148CrossRefPubMed Ruiz S, Santos M, Segrelles C, Leis H, Jorcano JL, Berns A, Paramio JM, Vooijs M: Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development. 2004, 131: 2737-2748. 10.1242/dev.01148CrossRefPubMed
44.
go back to reference Drozdoff V, Pledger WJ: Commitment to differentiation and expression of early differentiation markers in murine keratinocytes in vitro are regulated independently of extracellular calcium concentrations. J Cell Biol. 1993, 123: 909-919. 10.1083/jcb.123.4.909CrossRefPubMed Drozdoff V, Pledger WJ: Commitment to differentiation and expression of early differentiation markers in murine keratinocytes in vitro are regulated independently of extracellular calcium concentrations. J Cell Biol. 1993, 123: 909-919. 10.1083/jcb.123.4.909CrossRefPubMed
45.
go back to reference Moody CA, Fradet-Turcotte A, Archambault J, Laimins LA: Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci USA. 2007, 104: 19541-19546. 10.1073/pnas.0707947104PubMedCentralCrossRefPubMed Moody CA, Fradet-Turcotte A, Archambault J, Laimins LA: Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci USA. 2007, 104: 19541-19546. 10.1073/pnas.0707947104PubMedCentralCrossRefPubMed
46.
go back to reference Kikuchi A: Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci. 2003, 94: 225-229. 10.1111/j.1349-7006.2003.tb01424.xCrossRefPubMed Kikuchi A: Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci. 2003, 94: 225-229. 10.1111/j.1349-7006.2003.tb01424.xCrossRefPubMed
47.
go back to reference Clevers H: Wnt/β-catenin signalling in development and disease. Cell. 2006, 127: 469-480. 10.1016/j.cell.2006.10.018CrossRefPubMed Clevers H: Wnt/β-catenin signalling in development and disease. Cell. 2006, 127: 469-480. 10.1016/j.cell.2006.10.018CrossRefPubMed
48.
go back to reference Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P, Huber M, Hohl D, Cano A, Birchmeier W, Huelsken J: Cutaneous cancer stem cell maintenance is dependent on β-catenin signaling. Nature. 2008, 452: 650-653. 10.1038/nature06835CrossRefPubMed Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P, Huber M, Hohl D, Cano A, Birchmeier W, Huelsken J: Cutaneous cancer stem cell maintenance is dependent on β-catenin signaling. Nature. 2008, 452: 650-653. 10.1038/nature06835CrossRefPubMed
49.
go back to reference Lagunas-Martinez A, Madrid-Marina V, Gariglio P: Modulation of apoptosis by early human papillomavirus proteins in cervical cancer. Biochim Biophys Acta. 2010, 1805: 6-16.PubMed Lagunas-Martinez A, Madrid-Marina V, Gariglio P: Modulation of apoptosis by early human papillomavirus proteins in cervical cancer. Biochim Biophys Acta. 2010, 1805: 6-16.PubMed
50.
go back to reference Park J, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, Chang W, Meng Z, Cheung P, Ji H, McLaughlin M, Veenstra TD, Nusse R, McCrea PD, Artandi SE: Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009, 460: 66-72. 10.1038/nature08137PubMedCentralCrossRefPubMed Park J, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, Chang W, Meng Z, Cheung P, Ji H, McLaughlin M, Veenstra TD, Nusse R, McCrea PD, Artandi SE: Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009, 460: 66-72. 10.1038/nature08137PubMedCentralCrossRefPubMed
51.
go back to reference Bontkes HJ, van Duin M, De Gruijil TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA: HPV 16 infection and progression of cervical intraepithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer. 1998, 78: 166-171. 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO;2-XCrossRefPubMed Bontkes HJ, van Duin M, De Gruijil TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA: HPV 16 infection and progression of cervical intraepithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer. 1998, 78: 166-171. 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO;2-XCrossRefPubMed
52.
go back to reference Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Bartholomew JS, Joung LS, Stern PL: The association of an HPV 16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med. 1995, 1: 464-470. 10.1038/nm0595-464CrossRefPubMed Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Bartholomew JS, Joung LS, Stern PL: The association of an HPV 16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med. 1995, 1: 464-470. 10.1038/nm0595-464CrossRefPubMed
Metadata
Title
Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential
Authors
Ingeborg Zehbe
Hava Lichtig
Ashley Westerback
Paul F Lambert
Massimo Tommasino
Levana Sherman
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2011
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-10-77

Other articles of this Issue 1/2011

Molecular Cancer 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine